Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C P Schröder

Showing results (1-10 of 18) with videos related to

Pageof 2
Sort By:
European Journal of Pediatrics|May 22, 1978
Ultramicro-electrophoresis of protein in sweat from patients with cystic fibrosis of the pancreas and controlsC P Schröder, H M Emrich
Cancer Immunology, Immunotherapy : CII|June 13, 2001
Tributyrin enhances the cytotoxic activity of interleukin-2/interleukin-12 stimulated human natural killer cells against LS 174T colon cancer cells in vitroC P Schröder, H R Maurer
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 29, 2000
Purging of epithelial tumor cells from peripheral blood stem cells by means of the bispecific antibody BIS-1C P Schröder, B J Kroesen, L F de Leij, et al.
Cancer Chemotherapy and Pharmacology|January 1, 1995
Serotonin metabolism following platinum-based chemotherapy combined with the serotonin type-3 antagonist tropisetronC P Schröder, W T van der Graaf, I P Kema, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|September 13, 2019
Distress, problems, referral wish, and supportive health care use in breast cancer survivors beyond the first year after chemotherapy completionJ M Admiraal, J E H M Hoekstra-Weebers, C P Schröder, et al.
The Journal of Antimicrobial Chemotherapy|June 26, 1999
Prevention of febrile leucopenia after chemotherapy in high-risk breast cancer patients: no significant difference between granulocyte-colony stimulating growth factor or ciprofloxacin plus amphotericin BC P Schröder, E G de Vries, N H Mulder, et al.
Human Reproduction (Oxford, England)|April 9, 2004
An in vitro model for purging of tumour cells from ovarian tissueC P Schröder, H Timmer-Bosscha, J G Wijchman, et al.
European Journal of Nuclear Medicine and Molecular Imaging|July 31, 2018
<sup>89</sup>Zr-trastuzumab PET supports clinical decision making in breast cancer patients, when HER2 status cannot be determined by standard work upFrederike Bensch, A H Brouwers, M N Lub-de Hooge, et al.
EJNMMI Research|August 25, 2019
Enhanced pulmonary uptake on <sup>18</sup>F-FES-PET/CT scans after irradiation of the thoracic area: related to fibrosis?C M Venema, E F J de Vries, S J van der Veen, et al.
British Journal of Cancer|May 18, 2001
Telomere length in breast cancer patients before and after chemotherapy with or without stem cell transplantationC P Schröder, G B Wisman, S de Jong, et al.
Pageof 2

Showing results (1-10 of 18) with videos related to

Sort By:
Pageof 2
European Journal of Pediatrics|May 22, 1978
Ultramicro-electrophoresis of protein in sweat from patients with cystic fibrosis of the pancreas and controlsC P Schröder, H M Emrich
Cancer Immunology, Immunotherapy : CII|June 13, 2001
Tributyrin enhances the cytotoxic activity of interleukin-2/interleukin-12 stimulated human natural killer cells against LS 174T colon cancer cells in vitroC P Schröder, H R Maurer
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 29, 2000
Purging of epithelial tumor cells from peripheral blood stem cells by means of the bispecific antibody BIS-1C P Schröder, B J Kroesen, L F de Leij, et al.
Cancer Chemotherapy and Pharmacology|January 1, 1995
Serotonin metabolism following platinum-based chemotherapy combined with the serotonin type-3 antagonist tropisetronC P Schröder, W T van der Graaf, I P Kema, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|September 13, 2019
Distress, problems, referral wish, and supportive health care use in breast cancer survivors beyond the first year after chemotherapy completionJ M Admiraal, J E H M Hoekstra-Weebers, C P Schröder, et al.
The Journal of Antimicrobial Chemotherapy|June 26, 1999
Prevention of febrile leucopenia after chemotherapy in high-risk breast cancer patients: no significant difference between granulocyte-colony stimulating growth factor or ciprofloxacin plus amphotericin BC P Schröder, E G de Vries, N H Mulder, et al.
Human Reproduction (Oxford, England)|April 9, 2004
An in vitro model for purging of tumour cells from ovarian tissueC P Schröder, H Timmer-Bosscha, J G Wijchman, et al.
European Journal of Nuclear Medicine and Molecular Imaging|July 31, 2018
<sup>89</sup>Zr-trastuzumab PET supports clinical decision making in breast cancer patients, when HER2 status cannot be determined by standard work upFrederike Bensch, A H Brouwers, M N Lub-de Hooge, et al.
EJNMMI Research|August 25, 2019
Enhanced pulmonary uptake on <sup>18</sup>F-FES-PET/CT scans after irradiation of the thoracic area: related to fibrosis?C M Venema, E F J de Vries, S J van der Veen, et al.
British Journal of Cancer|May 18, 2001
Telomere length in breast cancer patients before and after chemotherapy with or without stem cell transplantationC P Schröder, G B Wisman, S de Jong, et al.
Pageof 2